Cervical scan test to find high-risk abnormal cervix cells
Part of Cancer, Women’s health & pregnancy clinical trials.
This study checks whether an advanced cervical scanning test (LuViva) can better identify people who may have serious precancer or early cancer of the cervix. You may be asked to have the scan around the time you are already scheduled for a colposcopy because your screening results were concerning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can read or understand the study info and sign consent
- You had a Pap test within the last 120 days
- Your clinician has scheduled a colposcopy based on your risk level from screening results
- You are not pregnant
- You are able to complete the exam while not having heavy bleeding or interfering discharge that could block the Pap test or scan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two treatments—LLETZ versus LEEP—for high-grade abnormal cells on the cervix. It may help decide which procedure works best and is safest for clearing these abnormal areas.
This study tests if a self-collected sample for HPV testing works as well as standard colposcopy to prevent cervical cancer. If you've recently had an abnormal cervical cancer screening and need a colposcopy, this trial may be an option for you.
This trial compares a liquid-based cytology test with a molecular screening test to find early changes in the cervix that could lead to cancer. It may help you understand which test is better at detecting these changes before they become serious.
This study compares two methods for finding abnormal cells in the cervix or vagina: a special type of endoscopy with high-definition imaging and the standard colposcopy. If you need a colposcopy because of certain HPV or Pap test results, this trial may help determine if the newer method is as good or better.
This study compares two methods for finding early signs of cervical cancer during a routine exam. It may help doctors detect problems sooner and prevent cancer from developing.
This study tests a new technology to help find cervical cancer earlier by focusing on people who already had an abnormal screening result. It may help improve how abnormal tests are checked and diagnosed.
Hear when a new Cervical Dysplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.